HROW
HARROW, INC.
Latest Form 4:Sale$450KbyShojaei Amir (CHIEF SCIENTIFIC OFFICER) · filed Aug 17, 2026
HARROW, INC. (HROW) has 10 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Aug 17, 2026.
The most active filer is 10% Owner Opaleye Management Inc. with 4 filings. Insiders have net sold $8.1M over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Mark L. Baum
- Employees:382
- HQ:Nashville, TN, US
- IPO:2007-09-28
Insider Buying
$469K
reported purchases (SEC code P)
Insider Selling
$9.6M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$1.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Shojaei AmirFirst filing | CHIEF SCIENTIFIC OFFICER | Sale | 11,250 | $450K | Aug 17 | SEC ↗ |
Graves Adrienne LFirst filing | Director | Purchase | 1,000 | $31K | May 19 | SEC ↗ |
SILVERNAIL LAUREN PFirst filing | Director | Purchase | 1,000 | $31K | May 19 | SEC ↗ |
BAUM MARK LFirst filing | CHIEF EXECUTIVE OFFICER | Purchase | 10,000 | $302K | May 15 | SEC ↗ |
BOLL ANDREW R.First filing | PRESIDENT AND CFO | Purchase | 3,500 | $105K | May 15 | SEC ↗ |
| 10% Owner | Sale | 60,309 | $2.4M | Mar 5 | SEC ↗ | |
| 10% Owner | Sale | 138,263 | $5.5M | Mar 5 | SEC ↗ | |
| 10% Owner | Sale | 5,000 | $271K | Mar 3 | SEC ↗ | |
| 10% Owner | Sale | 20,000 | $1.1M | Jan 8 | SEC ↗ |
Related companies
HARROW, INC. is in the Healthcare sector.